Vallely, Andrew

Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K. R., Gonzalez-Medina, D., Barber, R., Huynh, C., Dicker, D., et al. (2014) · The Lancet

Global Maternal and Child HealthMaternal and fetal healthcare

Cited by 1,644

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 335

Intravaginal and Menstrual Practices among Women Working in Food and Recreational Facilities in Mwanza, Tanzania: Implications for Microbicide Trials

Allen, C. F., Desmond, N., Chiduo, B., Medard, L., Lees, S. S., Vallely, A., Francis, S. C., Ross, D. A., & Hayes, R. J. (2010) · AIDS and Behavior

HIV/AIDS Research and InterventionsReproductive tract infections research

Cited by 43

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting

Vallely, A., Fitzgerald, L., Fiya, V., Aeno, H., Kelly, A., Sauk, J., Kupul, M., Neo, J., Millan, J., Siba, P., et al. (2012) · BMC Research Notes

HIV/AIDS Research and InterventionsReproductive Health and Contraception

Cited by 18